WallStSmart

Wellgistics Health, Inc. Common Stock (WGRX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Wellgistics Health, Inc. Common Stock stock (WGRX) is currently trading at $0.12. Wellgistics Health, Inc. Common Stock PS ratio (Price-to-Sales) is 0.45. WallStSmart rates WGRX as Sell.

  • WGRX PE ratio analysis and historical PE chart
  • WGRX PS ratio (Price-to-Sales) history and trend
  • WGRX intrinsic value — DCF, Graham Number, EPV models
  • WGRX stock price prediction 2025 2026 2027 2028 2029 2030
  • WGRX fair value vs current price
  • WGRX insider transactions and insider buying
  • Is WGRX undervalued or overvalued?
  • Wellgistics Health, Inc. Common Stock financial analysis — revenue, earnings, cash flow
  • WGRX Piotroski F-Score and Altman Z-Score
  • WGRX analyst price target and Smart Rating
WGRX

Wellgistics Health, Inc.

NASDAQHEALTHCARE
$0.12
$0.01 (-7.62%)
52W$0.11
$4.80

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Wellgistics Health, Inc. Common Stock (WGRX) · 7 metrics scored

Smart Score

26
out of 100
Grade: F
Avoid
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.

Wellgistics Health, Inc. Common Stock (WGRX) Key Strengths (2)

Avg Score: 9.0/10
Price/SalesValuation
0.4510/10

Paying less than $1 for every $1 of annual revenue

Price/BookValuation
1.818/10

Trading at 1.81x book value, attractively priced

Supporting Valuation Data

Price/Sales (TTM)
0.448
Undervalued
EV/Revenue
1.005
Undervalued

Wellgistics Health, Inc. Common Stock (WGRX) Areas to Watch (5)

Avg Score: 1.0/10
Return on EquityProfitability
-928.00%0/10

Company is destroying shareholder value

Operating MarginProfitability
-766.00%0/10

Losing money on operations

Revenue GrowthGrowth
-86.50%0/10

Revenue declining -86.50%, a shrinking business

Institutional Own.Quality
1.85%2/10

Very low institutional interest at 1.85%

Market CapQuality
$10M3/10

Micro-cap company with very limited liquidity and high volatility

Wellgistics Health, Inc. Common Stock (WGRX) Detailed Analysis Report

Overall Assessment

This company scores 26/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 2 register as strengths (avg 9.0/10) while 5 fall into concern territory (avg 1.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.45), Price/Book (1.81) suggest the stock is attractively priced.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -86.50%, which may limit upside. Profitability pressure is visible in Return on Equity at -928.00%, Operating Margin at -766.00%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -928.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -86.50% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

WGRX Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

WGRX's Price-to-Sales ratio of 0.45x sits near its historical average of 0.52x (14th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 38% below its historical high of 0.72x set in Mar 2026, and 24% above its historical low of 0.36x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.7x as trailing revenue scaled faster than the stock price.

Compare WGRX with Competitors

Top PHARMACEUTICAL RETAILERS stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Wellgistics Health, Inc. Common Stock (WGRX) · HEALTHCAREPHARMACEUTICAL RETAILERS

The Big Picture

Wellgistics Health, Inc. Common Stock operates as a stable business with moderate growth and solid fundamentals. Revenue reached 23M with 87% decline year-over-year.

Key Findings

Revenue Decline

Revenue contracted 87% YoY. Worth determining whether this is cyclical or structural.

Negative Free Cash Flow

Free cash flow is -6M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.

What to Watch Next

Sector dynamics: monitor PHARMACEUTICAL RETAILERS industry trends, competitive moves, and regulatory changes that could impact Wellgistics Health, Inc. Common Stock.

Bottom Line

Wellgistics Health, Inc. Common Stock offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Total Buys
0
Total Sells
0

Data sourced from SEC Form 4 filings

Last updated: 10:09:18 AM

About Wellgistics Health, Inc. Common Stock(WGRX)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

PHARMACEUTICAL RETAILERS

Country

USA

Wellgistics Health, Inc. is a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company is headquartered in Tampa, Florida.